User profiles for D. M. Gendoo
Deena MA GendooAssociate Professor in Computational Biology, University of Birmingham Verified email at bham.ac.uk Cited by 1806 |
Circulating tumour DNA detects somatic variants contributing to spatial and temporal intratumoural heterogeneity in head and neck squamous cell carcinoma
Background - As circulating tumour DNA (ctDNA) liquid biopsy analysis is increasingly
incorporated into modern oncological practice, establishing the impact of genomic intra-tumoural …
incorporated into modern oncological practice, establishing the impact of genomic intra-tumoural …
[PDF][PDF] The common analgesic paracetamol enhances the anti-tumour activity of decitabine through exacerbation of oxidative stress
The common analgesic paracetamol enhances the anti-tumour activity of decitabine through
exacerbation of oxidative stress Conf Page 1 1 The common analgesic paracetamol enhances …
exacerbation of oxidative stress Conf Page 1 1 The common analgesic paracetamol enhances …
[PDF][PDF] Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors
…, L Letourneau, M Bourgey, M Yu, DMA Gendoo… - Cancer cell, 2016 - cell.com
We recently reported that atypical teratoid rhabdoid tumors (ATRTs) comprise at least two
transcriptional subtypes with different clinical outcomes; however, the mechanisms underlying …
transcriptional subtypes with different clinical outcomes; however, the mechanisms underlying …
[HTML][HTML] MM2S: personalized diagnosis of medulloblastoma patients and model systems
DMA Gendoo, B Haibe-Kains - Source Code for Biology and Medicine, 2016 - Springer
Background Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour
that is the most common cause of cancer-related deaths in children. Increasing availability of …
that is the most common cause of cancer-related deaths in children. Increasing availability of …
[HTML][HTML] The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of …
The DNA demethylating agent 5-aza-2′-deoxycytidine (DAC, decitabine) has anti-cancer
therapeutic potential, but its clinical efficacy is hindered by DNA damage-related side effects …
therapeutic potential, but its clinical efficacy is hindered by DNA damage-related side effects …
Public data and open source tools for multi-assay genomic investigation of disease
… Deena MA Gendoo is a postdoctoral research fellow at the Princess Margaret Cancer Centre,
Canada. Her research focuses on translational bioinformatics in multiple cancer types, as …
Canada. Her research focuses on translational bioinformatics in multiple cancer types, as …
Bioinformatic sequence and structural analysis for Amyloidogenicity in Prions and other proteins
D Gendoo - 2012 - escholarship.mcgill.ca
Detection of amyloidogenic peptides or domains in proteins is of paramount importance towards
understanding their role in amyloidosis in conformational diseases. This thesis explores …
understanding their role in amyloidosis in conformational diseases. This thesis explores …
[HTML][HTML] Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
PED Chung, DMA Gendoo… - Nature …, 2020 - nature.com
Pineoblastoma is a rare pediatric cancer induced by germline mutations in the tumor
suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor …
suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor …
[HTML][HTML] A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt …
DY Wang, DMA Gendoo, Y Ben-David… - Breast cancer …, 2019 - Springer
Background Triple-negative breast cancer (TNBC) represents a heterogeneous group of ER-
and HER2-negative tumors with poor clinical outcome. We recently reported that Pten-loss …
and HER2-negative tumors with poor clinical outcome. We recently reported that Pten-loss …
[HTML][HTML] Ulinastatin administration is associated with a lower incidence of acute kidney injury after cardiac surgery: a propensity score matched study
X Wan, X Xie, Y Gendoo, X Chen, X Ji, C Cao - Critical Care, 2016 - Springer
Background Systemic inflammation is involved in the development of acute kidney injury (AKI)
after cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urinary trypsin …
after cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urinary trypsin …